Sells ophthalmic medical devices and surgical products to medical institutions worldwide.
10-K for FY2026, filed Oct 13, 2026The Company operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices…View ↗
The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in…View ↗
The Company markets disposable surgical packs used in vitreoretinal surgery, including packs which aid surgeons in the process of injecting…View ↗
The Company's products are sold through independent sales representatives, a network of distributors, and internal sales employees directly…View ↗
Customers are billed for device sales when products ship and for AXIS installation and care plans after installation; care-plan service is provided over the service period.
10-K for FY2026, filed Oct 13, 2026The Company generates product revenue from the sale of medical device products and the sale and installation of the Company's AXIS image…View ↗
The product sales and installation of AXIS image management system software performance obligations are satisfied at a point in time, which…View ↗
The Company invoices its customers upon shipment for product sales. For the installation of AXIS image management system software and…View ↗
Revenue for product sales and installation of AXIS image management system software is recognized when delivered or installed. The customer…View ↗
10-K for FY2026, filed Oct 13, 2026
FY2026 revenue by product or service ↗$12.7M
10-K for FY2026, filed Oct 13, 2026
$12.7M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2026, filed Oct 13, 2026 |
95%
FY2023: 95%
|
Product, FY2026
$12.1M Sources
|
Sold outright |
|
Service
Recurring
|
5.1%
FY2023: 5.1%
|
Service, FY2026
$653.5K Sources
|
Recurring |
Medical institutions worldwide buy through independent sales representatives and distributors, or directly from internal sales employees.
10-K for FY2026, filed Oct 13, 2026The Company's products are sold through independent sales representatives, a network of distributors, and internal sales employees directly…View ↗
10-K for FY2026, filed Oct 13, 2026
One customer accounted for approximately 12% of net sales during the year ended June 30, 2026. One customer accounted for approximately 17%…View ↗
Yes. It kept 32 cents of every revenue dollar as net income in FY2026, but spent more cash than it brought in: free cash flow was −$407K.
10-K for FY2026, filed Oct 13, 2026
10-K for FY2026, filed Oct 13, 2026
$45.2KView ↗
10-K for FY2026, filed Oct 13, 2026
$4MView ↗
10-K for FY2026, filed Oct 13, 2026
−$407KView ↗
Growing. Revenue grew 19% in 4 years, from $10.7M in FY2022 to $12.7M in FY2026, about 4% a year.
AXIS software sale The older report describes the AXIS Image Management system as a company product; the latest report says the company sold its AXIS software.
Competes with Quantel, Accutome, Alcon Laboratories, Bausch & Lomb, Carl Zeiss Meditec, and Topcon Healthcare Solutions
10-K for FY2023, filed Oct 13, 2023Sonomed’s principal competitors are Quantel, Inc., and Accutome, Inc.. Sonomed has had a leading presence in the ophthalmic ultrasound…View ↗
Loading...